![Ids van der Weij](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ids van der Weij
Directeur/Membre du Conseil chez
SEQUANA MEDICAL N.V.
Profil
Ids van der Weij is currently the Managing Director at OOK Capital Partners BV since 2013.
He is also a Non-Executive Director at Sequana Medical NV since 2023.
Additionally, he holds positions as a Director at Diceros Therapeutics, Inc., and as a Member-Supervisory Board at both Micreos BV and ArboNed BV.
In the past, Mr. van der Weij worked as the Managing Director at Friesland Bank Investments BV.
He also served as a Director at the Nederlandse Vereniging van Participatiemaatschappijen and was a Member-Supervisory Board at Ophtec BV.
Mr. van der Weij completed his undergraduate degree at the University of Groningen.
Postes actifs de Ids van der Weij
| Sociétés | Poste | Début |
|---|---|---|
| SEQUANA MEDICAL N.V. | Directeur/Membre du Conseil | 10/11/2023 |
OOK Capital Partners BV
 OOK Capital Partners BV Investment ManagersFinance OOK Capital Partners is a manager which provides equity funding for growth and later stage companies. The investment period has closed and it focusses on current portfolios. | Private Equity Investor | 01/12/2013 |
ArboNed BV
 ArboNed BV Miscellaneous Commercial ServicesCommercial Services Provides professional services which focuses on the long-term employability of workers | Directeur/Membre du Conseil | - |
Diceros Therapeutics Inc
 Diceros Therapeutics Inc Miscellaneous Commercial ServicesCommercial Services Provides biotechnology healthcare services | Directeur/Membre du Conseil | - |
Micreos BV
 Micreos BV Pharmaceuticals: MajorHealth Technology Operates as a biotech platform company that develops recombinant proteins for chronic dermatology conditions | Directeur/Membre du Conseil | - |
Anciens postes connus de Ids van der Weij
| Sociétés | Poste | Fin |
|---|---|---|
Friesland Bank Investments BV
 Friesland Bank Investments BV Investment ManagersFinance FBI is an active, long-term manager which aims to invest in medium-sized businesses in all sectors except biotechnology, hotel & restaurant and real estate. The firm focuses on companies with an operating profit of 0.5-10 million euros, typically investing 3-8 million euros. For larger amounts or in specific situations, they work together with other investors. FBI seeks to invest in companies with a sound business plan and established market position, taking minority or majority positions and partnering with the investee management team to develop and implement strategic decisions. The firm generally holds an investment for three to eight years, exiting at the time agreed with the investee company stakeholders during their shareholding. | President | 30/11/2012 |
Ophtec BV
 Ophtec BV Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Directeur/Membre du Conseil | - |
Nederlandse Vereniging van Participatiemaatschappijen | Directeur/Membre du Conseil | - |
Formation de Ids van der Weij
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Micreos BV
Micreos BV Pharmaceuticals: MajorHealth Technology Operates as a biotech platform company that develops recombinant proteins for chronic dermatology conditions | Health Technology |
Friesland Bank Investments BV
Friesland Bank Investments BV Investment ManagersFinance FBI is an active, long-term manager which aims to invest in medium-sized businesses in all sectors except biotechnology, hotel & restaurant and real estate. The firm focuses on companies with an operating profit of 0.5-10 million euros, typically investing 3-8 million euros. For larger amounts or in specific situations, they work together with other investors. FBI seeks to invest in companies with a sound business plan and established market position, taking minority or majority positions and partnering with the investee management team to develop and implement strategic decisions. The firm generally holds an investment for three to eight years, exiting at the time agreed with the investee company stakeholders during their shareholding. | Finance |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ophtec BV
Ophtec BV Medical SpecialtiesHealth Technology Manufactures and markets medical devices | Health Technology |
ArboNed BV
ArboNed BV Miscellaneous Commercial ServicesCommercial Services Provides professional services which focuses on the long-term employability of workers | Commercial Services |
Nederlandse Vereniging van Participatiemaatschappijen | |
OOK Capital Partners BV
OOK Capital Partners BV Investment ManagersFinance OOK Capital Partners is a manager which provides equity funding for growth and later stage companies. The investment period has closed and it focusses on current portfolios. | Finance |
Sequana Medical NV
 Sequana Medical NV Medical SpecialtiesHealth Technology Manufactures and distributes electro medical devices like alfa pump to remove excess fluid in patients with liver disease & heart failure | Health Technology |
Diceros Therapeutics Inc
Diceros Therapeutics Inc Miscellaneous Commercial ServicesCommercial Services Provides biotechnology healthcare services | Commercial Services |
